{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:38:38Z","timestamp":1792597118810,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cll.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:22:10Z","timestamp":1787390530000},"page":"643-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Battle of Technologies"],"prefix":"10.1016","volume":"46","author":[{"given":"Alec","family":"Saitman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Knezevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Badea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 1","key":"10.1016\/j.cll.2026.07.005_bib1","article-title":"Overview of therapeutic drug monitoring and clinical practice","volume":"266","author":"Fang","year":"2024","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.cll.2026.07.005_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/bmm-2018-0355","article-title":"Pharmacodynamic monitoring using biomarkers to individualize pharmacotherapy","volume":"13","author":"Theile","year":"2019","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.cll.2026.07.005_bib3","article-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","year":"2018"},{"key":"10.1016\/j.cll.2026.07.005_bib4","article-title":"Contemporary Practice in Clinical Chemistry","year":"2020"},{"key":"10.1016\/j.cll.2026.07.005_bib5","article-title":"Using residual blood from the arterial blood gas test to perform therapeutic drug monitoring of vancomycin: an example of good clinical practice moving towards a sustainable intensive care unit","volume":"2022","author":"Smeets","year":"2022","journal-title":"Crit Care Res Pract"},{"issue":"10","key":"10.1016\/j.cll.2026.07.005_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01245-19","article-title":"Impact of triazole therapeutic drug monitoring availability and timing","volume":"63","author":"McCreary","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.cll.2026.07.005_bib7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/FTD.0000000000000777","article-title":"Comparison of novel immunoassay with liquid chromatography\/tandem mass spectrometry (LC-MS\/MS) for therapeutic drug monitoring of clozapine","volume":"42","author":"Buckley","year":"2020","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jalm\/jfaf199","article-title":"Tacrolimus assay comparison: analytical and operational considerations for immunoassay vs mass spectrometry testing in a high volume clinical laboratory","volume":"11","author":"Goldblatt","year":"2026","journal-title":"J Appl Lab Med"},{"issue":"6","key":"10.1016\/j.cll.2026.07.005_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jalm\/jfab062","article-title":"Multi-site evaluation of immunoassays for antipsychotic drug measurement in clinical samples","volume":"6","author":"Clarke","year":"2021","journal-title":"J Appl Lab Med"},{"issue":"12","key":"10.1016\/j.cll.2026.07.005_bib10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5858\/arpa.2020-0562-CP","article-title":"Therapeutic drug monitoring of Second- and third-generation antiepileptic drugs","volume":"145","author":"Krasowski","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"17\u201318","key":"10.1016\/j.cll.2026.07.005_bib11","first-page":"1","article-title":"Interference from anti-drug antibodies on the quantification of insulin: a comparison of an LC-MS\/MS assay and immunoassays","volume":"16","author":"Varga","year":"2024","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.cll.2026.07.005_bib12","first-page":"9","article-title":"Falsely elevated vancomycin-concentration values from enzyme immunoassay leading to treatment failure","volume":"77","author":"Singer","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.cll.2026.07.005_bib13","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1515\/cclm-2025-0251","article-title":"Vancomycin assay interference: low-level IgM paraprotein disrupts siemens Atellica((R)) CH VANC assay","volume":"63","author":"De Koninck","year":"2025","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/FTD.0000000000000696","article-title":"Comparison of 4 commercial immunoassays used in measuring the concentration of tacrolimus in blood and their cross-reactivity to its metabolites","volume":"42","author":"Shigematsu","year":"2020","journal-title":"Ther Drug Monit"},{"issue":"6","key":"10.1016\/j.cll.2026.07.005_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/FTD.0000000000001246","article-title":"Lack of interchangeability between 3 different methods for quantification of everolimus in blood: ACMIA, LTIA, and UHPLC-MS\/MS","volume":"46","author":"Miyagi","year":"2024","journal-title":"Ther Drug Monit"},{"issue":"9","key":"10.1016\/j.cll.2026.07.005_bib16","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1515\/cclm-2025-0186","article-title":"Standardization challenges in antipsychotic drug monitoring: insights from a national survey in Chinese TDM practices","volume":"63","author":"Zhou","year":"2025","journal-title":"Clin Chem Lab Med"},{"issue":"e1","key":"10.1016\/j.cll.2026.07.005_bib17","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/ejhpharm-2018-001616","article-title":"Therapeutic drug monitoring of levetiracetam in daily clinical practice: high-performance liquid chromatography versus immunoassay","volume":"27","author":"Mendoza Aguilera","year":"2020","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"10.1016\/j.cll.2026.07.005_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/FTD.0000000000000953","article-title":"Quantification of antibiotics in patient samples: state of the art in standardization and proficiency testing","volume":"44","author":"Schneider","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"11","key":"10.1016\/j.cll.2026.07.005_bib19","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","article-title":"Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation","volume":"26","author":"Gomez-Lopez","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.cll.2026.07.005_bib20","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/jac\/dkad289","article-title":"A novel strategy for therapeutic drug monitoring: application of biosensors to quantify antimicrobials in biological matrices","volume":"78","author":"Wang","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cll.2026.07.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2025.125840","article-title":"Antibody-based surface plasmon resonance sensor platform for monitoring amikacin drug concentrations in human serum samples","volume":"333","author":"Li","year":"2025","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"issue":"6","key":"10.1016\/j.cll.2026.07.005_bib22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jpha.2022.06.003","article-title":"Development of a surface plasmon resonance biosensor for accurate and sensitive quantitation of small molecules in blood samples","volume":"12","author":"Qi","year":"2022","journal-title":"J Pharm Anal"},{"issue":"23","key":"10.1016\/j.cll.2026.07.005_bib23","doi-asserted-by":"crossref","first-page":"12051","DOI":"10.1021\/acs.analchem.4c06748","article-title":"Therapeutic drug monitoring of Amikacin and colistin in patients with multidrug-resistant gram-negative infections using a portable plasmonic biosensor","volume":"97","author":"Astua","year":"2025","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.cll.2026.07.005_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1515\/cclm-2022-0949","article-title":"Surface plasmon resonance assays for the therapeutic drug monitoring of infliximab indicate clinical relevance of anti-infliximab antibody binding properties","volume":"61","author":"Grasmeier","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cll.2026.07.005_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110838","article-title":"Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensor","volume":"133-134","author":"Di Santo","year":"2024","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cll.2026.07.005_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bios.2014.03.047","article-title":"Detection of the antiepileptic drug phenytoin using a single free-standing piezoresistive microcantilever for therapeutic drug monitoring","volume":"59","author":"Huang","year":"2014","journal-title":"Biosens Bioelectron"},{"issue":"2","key":"10.1016\/j.cll.2026.07.005_bib27","article-title":"Biosensor-enabled multiplexed On-Site therapeutic drug monitoring of antibiotics","volume":"34","author":"Ates","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.cll.2026.07.005_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.343473","article-title":"Therapeutic drug monitoring of methotrexate by disposable SPCE biosensor for personalized medicine","volume":"1335","author":"Liu","year":"2025","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cll.2026.07.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338250","article-title":"A fluorescence biosensor for therapeutic drug monitoring of vancomycin using in vivo microdialysis","volume":"1151","author":"Mu","year":"2021","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cll.2026.07.005_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.341431","article-title":"Fluorimetric monitoring of vancomycin using an allosteric probe-initiated sensing platform","volume":"1269","author":"Yuan","year":"2023","journal-title":"Anal Chim Acta"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib31","article-title":"Smartphone biosensors for non-invasive drug monitoring in saliva","volume":"15","author":"Awad","year":"2025","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.cll.2026.07.005_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115363","article-title":"Wireless, noninvasive therapeutic drug monitoring system for saliva measurement toward medication management of schizophrenia","volume":"234","author":"Yan","year":"2023","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.cll.2026.07.005_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115437","article-title":"Simultaneous determination of 24 antiepileptic drugs and their active metabolites in human plasma by UHPLC-MS\/MS","volume":"232","author":"Jiang","year":"2023","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"10.1016\/j.cll.2026.07.005_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5090","article-title":"A UPLC-MS\/MS method for simultaneous determination of nine antiepileptic drugs in human plasma and its application in TDM","volume":"35","author":"Qi","year":"2021","journal-title":"Biomed Chromatogr"},{"issue":"8","key":"10.1016\/j.cll.2026.07.005_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5393","article-title":"LC-MS\/MS quantification of levetiracetam, lamotrigine and 10-hydroxycarbazepine in TDM of epileptic patients","volume":"36","author":"Zhou","year":"2022","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/FTD.0000000000000252","article-title":"Evaluation of the waters MassTrak LC-MS\/MS assay for tacrolimus and a comparison to the Abbott Architect Immunoassay","volume":"38","author":"Saitman","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.005_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jmsacl.2023.02.004","article-title":"How the VALID Act could affect patient access to laboratory developed testing for therapeutic drug monitoring","volume":"28","author":"Saitman","year":"2023","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/00498254.2025.2498702","article-title":"LC-MS\/MS determination of 27 antipsychotics and metabolites in plasma for medication management monitoring","volume":"55","author":"Chen","year":"2025","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cll.2026.07.005_bib39","article-title":"High-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of 23 antidepressants and active metabolites in human serum and its application in therapeutic drug monitoring","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cll.2026.07.005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2024.107568","article-title":"Evaluation of 4 quantification methods for monitoring 16 antidepressant drugs and their metabolites in human plasma by LC-MS\/MS","volume":"130","author":"Wang","year":"2024","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.cll.2026.07.005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2024.107565","article-title":"A general and rapid LC-MS\/MS method for simultaneous determination of voriconazole, posaconazole, fluconazole, itraconazole and hydroxyitraconazole in IFI patients","volume":"130","author":"Xia","year":"2024","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"7","key":"10.1016\/j.cll.2026.07.005_bib42","first-page":"660","article-title":"Simultaneous quantification of vancomycin, linezolid and voriconazole in human plasma by UHPLC-MS\/MS: application in therapeutic drug monitoring","volume":"62","author":"Liu","year":"2024","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.cll.2026.07.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2024.115507","article-title":"Comparison of two acquisition modes in mass spectrometry for quantification of 12 antibiotics, including beta-lactams, linezolid, fluoroquinolones and clindamycin: multiple reactions monitoring (MRM) and fullMS\/dd-MS(2)","volume":"690","author":"Feliu","year":"2024","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/j.cll.2026.07.005_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5092","article-title":"A sensitive and high-throughput quantitative liquid chromatography high-resolution mass spectrometry method for therapeutic drug monitoring of 10 beta-lactam antibiotics, linezolid and two beta-lactamase inhibitors in human plasma","volume":"35","author":"Van Vooren","year":"2021","journal-title":"Biomed Chromatogr"},{"issue":"6","key":"10.1016\/j.cll.2026.07.005_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5071","article-title":"Simultaneous quantification of cyclosporin, tacrolimus, sirolimus and everolimus in whole blood by UHPLC-MS\/MS for therapeutic drug monitoring","volume":"35","author":"Antunes","year":"2021","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.cll.2026.07.005_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124100","article-title":"Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS\/MS in human plasma and its application to therapeutic drug monitoring in cancer patients","volume":"1237","author":"Zhao","year":"2024","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.cll.2026.07.005_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124039","article-title":"Liquid chromatography coupled to tandem mass spectrometry (LC-MS\/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: an update","volume":"1236","author":"Briki","year":"2024","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"8","key":"10.1016\/j.cll.2026.07.005_bib48","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/00140138508963240","article-title":"Fitness for work: bridging the gap in ergonomics","volume":"28","author":"Boudri","year":"1985","journal-title":"Ergonomics"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/FTD.0000000000000873","article-title":"Tacrolimus measured in capillary volumetric microsamples in pediatric Patients-A cross-validation study","volume":"43","author":"Kindem","year":"2021","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.cll.2026.07.005_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40780-023-00318-6","article-title":"Validation of an automated sample preparation module directly connected to LC-MS\/MS (CLAM-LC-MS\/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting","volume":"10","author":"Shimada","year":"2024","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.cll.2026.07.005_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2022.11.029","article-title":"Cascadion SM Clinical Analyzer: evaluation of the whole blood immunosuppressants quantification and routine usability","volume":"539","author":"Mathieu","year":"2023","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.cll.2026.07.005_bib52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/FTD.0000000000001051","article-title":"Immunosuppressant monitoring-performance of the first mass spectrometry-based automated clinical analyzer cascadion","volume":"45","author":"Grote-Koska","year":"2023","journal-title":"Ther Drug Monit"},{"issue":"11","key":"10.1016\/j.cll.2026.07.005_bib53","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/bcp.15433","article-title":"Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients","volume":"88","author":"Zwart","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.cll.2026.07.005_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/FTD.0000000000001019","article-title":"Results from a proficiency testing pilot for immunosuppressant microsampling assays","volume":"45","author":"Veenhof","year":"2023","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.cll.2026.07.005_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/FTD.0000000000001282","article-title":"Alternate sampling matrices for therapeutic drug monitoring of immunosuppressants","volume":"47","author":"Sallustio","year":"2025","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cll.2026.07.005_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123721","article-title":"New perspectives for the therapeutic drug monitoring of tacrolimus: quantification in volumetric DBS based on an automated extraction and LC-MS\/MS analysis","volume":"1223","author":"Rose","year":"2023","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib57","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jalm\/jfaa005","article-title":"Volumetric microsampling of capillary blood spot vs whole blood sampling for therapeutic drug monitoring of tacrolimus and cyclosporin A: Accuracy and patient satisfaction","volume":"5","author":"Mbughuni","year":"2020","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.cll.2026.07.005_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339889","article-title":"Quantification of immunosuppressants from one 3.2 mm dried blood spot by a novel cold-induced phase separation based LC-MS\/MS method","volume":"1210","author":"Le","year":"2022","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cll.2026.07.005_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340797","article-title":"Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer(R) qDBS device","volume":"1242","author":"Deprez","year":"2023","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.cll.2026.07.005_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463724","article-title":"Dried blood microsampling-assisted therapeutic drug monitoring of immunosuppressants: an overview","volume":"1689","author":"Deprez","year":"2023","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.cll.2026.07.005_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116877","article-title":"Non-invasive therapeutic drug monitoring: LC-MS validation for lamotrigine quantification in dried blood spot and oral fluid\/saliva","volume":"262","author":"Pelcova","year":"2025","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cll.2026.07.005_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116099","article-title":"Simultaneous monitoring of seven antiepileptic drugs by dried blood spot and dried plasma spot sampling: method validation and clinical application of a LC-MS\/MS-based technique","volume":"243","author":"Cao","year":"2024","journal-title":"J Pharm Biomed Anal"},{"issue":"16","key":"10.1016\/j.cll.2026.07.005_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.10064","article-title":"Dried blood spot analysis for simultaneous quantification of antiepileptic drugs using liquid chromatography-tandem mass spectrometry","volume":"39","author":"Abady","year":"2025","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"10.1016\/j.cll.2026.07.005_bib64","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/FTD.0000000000000833","article-title":"Quantitation of tacrolimus in human whole blood samples using the MITRA microsampling device","volume":"43","author":"Undre","year":"2021","journal-title":"Ther Drug Monit"},{"issue":"7","key":"10.1016\/j.cll.2026.07.005_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14827","article-title":"Monitoring levetiracetam concentration in saliva during pregnancy is stable and feasible","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci Ther"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:41:16Z","timestamp":1792593676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271226000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0272271226000752"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2026.07.005","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Battle of Technologies","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}